Cover Image

Control of Healthcare-Associated Carbapenem-Resistant <i>Acinetobacter baumannii</i> by Enhancement of Infection Control Measures

Antimicrobial stewardship and infection control measures are equally important in the control of antimicrobial-resistant organisms. We conducted a retrospective analysis of the incidence rate of hospital-onset carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) infection (per 1000...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shuk-Ching Wong (Author), Pui-Hing Chau (Author), Simon Yung-Chun So (Author), Germaine Kit-Ming Lam (Author), Veronica Wing-Man Chan (Author), Lithia Lai-Ha Yuen (Author), Christine Ho-Yan Au Yeung (Author), Jonathan Hon-Kwan Chen (Author), Pak-Leung Ho (Author), Kwok-Yung Yuen (Author), Vincent Chi-Chung Cheng (Author)
Format:	Book
Published:	MDPI AG, 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gastrointestinal Colonization of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: What Is the Implication for Infection Control?
by: Shuk-Ching Wong, et al.
Published: (2022)

Epidemiology of multidrug-resistant organisms before and during COVID-19 in Hong Kong
by: Shuk-Ching Wong, et al.
Published: (2023)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023)

Biofilm-Induced Antibiotic Resistance in Clinical <i>Acinetobacter baumannii</i> Isolates
by: Abebe Mekuria Shenkutie, et al.
Published: (2020)

Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Yoon-Jung Choi, et al.
Published: (2024)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Tsung-Ying Yang, et al.
Published: (2021)

Exploration of New Drug Candidate Derived from Antioxidants of Korean Native Halophytes: Control of <i>Acinetobacter baumannii</i> with Antipathogenic Activity
by: Jihee Lee, et al.
Published: (2024)

Prevalence of Carbapenemases in Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates from the Kingdom of Bahrain
by: Nouf Al-Rashed, et al.
Published: (2023)

Is It Possible to Eradicate Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) from Endemic Hospitals?
by: Filippo Medioli, et al.
Published: (2022)

Dynamic Gene Clusters Mediating Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates
by: Samy Selim, et al.
Published: (2022)

Complex Infection-Control Measures with Disinfectant Switch Help the Successful Early Control of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Outbreak in Intensive Care Unit
by: Jozsef Kelemen, et al.
Published: (2024)

The Characterisation of Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> in a Teaching Hospital in Malaysia
by: Min Yi Lau, et al.
Published: (2024)

Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant <i>Acinetobacter baumannii</i> with Polymyxin-Based Combinations
by: Marisol Wences, et al.
Published: (2022)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021)

Comparative Transcriptomic Profiling of Pellicle and Planktonic Cells from Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Heng Kang Ng, et al.
Published: (2023)

Bibliometric Examination of Global Scientific Research about Carbapenem-Resistant <i>Acinetobacter Baumannii</i> (CRAB)
by: Himanshu Jangid, et al.
Published: (2023)

Colistin Resistance in <i>Acinetobacter baumannii:</i> Molecular Mechanisms and Epidemiology
by: Katarina Novović, et al.
Published: (2023)

Treatment Strategies of Colistin Resistance <i>Acinetobacter baumannii</i> Infections
by: Andria Papazachariou, et al.
Published: (2024)

<i>Acinetobacter baumannii</i> Infections in Hospitalized Patients, Treatment Outcomes
by: Diaa Alrahmany, et al.
Published: (2021)

Pan-Resistome Insights into the Multidrug Resistance of <i>Acinetobacter baumannii</i>
by: Diego Lucas Neres Rodrigues, et al.
Published: (2021)

DksA Modulates Antimicrobial Susceptibility of <i>Acinetobacter baumannii</i>
by: Nayeong Kim, et al.
Published: (2021)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020)

Investigating Bacteriophages Targeting the Opportunistic Pathogen <i>Acinetobacter baumannii</i>
by: Kathryn M. Styles, et al.
Published: (2020)

Prosthetic valve endocarditis caused by <i> Acinetobacter baumannii </i> complex
by: Kumar S, et al.
Published: (2008)

Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Filomena Sannio, et al.
Published: (2022)

Molecular Epidemiology of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates from Northern Africa and the Middle East
by: Paul G. Higgins, et al.
Published: (2021)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates
by: Harald Seifert, et al.
Published: (2023)

Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
by: Joonhyeok Choi, et al.
Published: (2021)

Rifampicin Enhanced Carbapenem Activity with Improved Antibacterial Effects and Eradicates Established <i>Acinetobacter baumannii</i> Biofilms
by: Lois Chinwe Nwabor, et al.
Published: (2023)

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i> in an Academic Medical Center in Thailand
by: Taniya Paiboonvong, et al.
Published: (2022)

<i>Acinetobacter baumannii</i> Resistance to Sulbactam/Durlobactam: A Systematic Review
by: Luigi Principe, et al.
Published: (2022)

The Role of Uniform Meropenem Usage in <i>Acinetobacter baumannii</i> Clone Replacement
by: Bence Balázs, et al.
Published: (2021)

Antibiotic Resistance and Genotypes of Nosocomial Strains of <i>Acinetobacter baumannii</i> in Kazakhstan
by: Alyona Lavrinenko, et al.
Published: (2021)

Novel Phage Lysin Abp013 against <i>Acinetobacter baumannii</i>
by: Joash Jun Keat Chu, et al.
Published: (2022)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>
by: Paraskevi Mantzana, et al.
Published: (2023)

RapidResa Polymyxin <i>Acinetobacter</i> NP<sup>®</sup> Test for Rapid Detection of Polymyxin Resistance in <i>Acinetobacter baumannii</i>
by: Maxime Bouvier, et al.
Published: (2021)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021)

Prevalence of Carbapenem Resistance Genes among <i>Acinetobacter baumannii</i> Isolated from a Teaching Hospital in Taiwan
by: Pai-Wei Su, et al.
Published: (2023)

Current State of Antimicrobial Treatment of Lower Respiratory Tract Infections Due to Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Marco Merli, et al.
Published: (2023)

Phenotypic and Genotypic Investigation of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Maharaj Nakhon Si Thammarat Hospital, Thailand
by: Sirijan Santajit, et al.
Published: (2023)